Eli Lilly and Company v. Ranbaxy Laboratories

Rule established

A patent for a pharmaceutical compound (Olanzapine) was held valid. Ranbaxy's challenge on grounds of obviousness and lack of novelty rejected. Process of selection from a known class of compounds can constitute a valid patent if the selection produces unexpected advantages.